"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Ind-Swift Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : N R Munjal
Home : Indian Private	Book Value: 169.257251
BSE Code : 532305	Market Cap: 639.53
NSE Code : INDSWFTLAB	P / E : 7.13

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Type	3Qtr	2Qtr	1Qtr	4Qtr
Net Sales	1.41	2.71	30.46	381.73
Other Income	13.81	12.95	11.14	411.84
Total Income	15.22	15.65	41.60	793.57
Total Expenditure	10.22	14.71	34.99	309.22
Operating Profit	5.00	0.95	6.61	484.35
Interest	0.11	0.41	0.17	-11.48
Gross Profit	4.88	0.54	6.44	495.83
Depreciation	0.25	0.22	0.25	12.67
Tax	0.00	0.00	0.00	144.41
Deferred Tax	0.00	0.00	0.00	-10.84
Reported Profit After Tax	4.64	0.32	6.19	349.59

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView